A Corrigendum on
Topological Modification of Brain Networks Organization in Children With High Intelligence Quotient: A Resting-State fMRI Study
by Suprano, I., Delon-Martin, C., Kocevar, G., Stamile, C., Hannoun, S., Achard, S., et al. (2019). Front. Hum. Neurosci. 13:241. doi: 10.3389/fnhum.2019.00241
In the original article, there was an error. It was not mentioned in the article that the HIQ group of children included children with either a FSIQ > 130 or a VCI > 130.
A correction has been made to the Materials and Methods, subsection Participants:
“Fifty-eight children (44 males and 14 females) ages 8–12 (mean age 10.1 ± 1.2) years were recruited from the children psychiatry department of Lyon's Neurological Hospital, the PSYRENE Center, a psychological center for high IQ children and adults, and via advertisement in schools for controls. Children with neurological diseases, learning disabilities, and psychotropic treatments were excluded from this study. Children underwent the fourth edition of WISC (WISC-IV) test and their FSIQ was established from the results of its four subscales (VCI, PRI, WMI, and PSI). Children with a high Intelligence Quotient (FSIQ > 130 or VCI > 130) were labeled as HIQ children and two HIQ profiles were defined based on score difference between VCI and PRI (Table 1). This prospective study was approved by the local ethics committee (CPP Sud-Est IV) and the French National Agency for Medicine and Health Products Safety (ANSM). Written informed consent was obtained from the parents of all participants.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Ilaria Suprano1, Chantal Delon-Martin2, Gabriel Kocevar1, Claudio Stamile1, Salem Hannoun3, Sophie Achard4, Amanpreet Badhwar5, Pierre Fourneret6, Olivier Revol6, Fanny Nusbaum7,8 and Dominique Sappey-Marinier1,9*
* 1Univ. Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Étienne, CNRS, INSERM, CREATIS UMR 5220, Lyon, France
* 2Univ. Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France
* 3Nehme and Therese Tohme Multiple Sclerosis Center, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
* 4GIPSA-Lab, UMR CNRS 5216, Université Grenoble Alpes, Grenoble, France
* 5Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Université de Montréal, Montreal, QC, Canada
* 6Service de Psychopathologie du Développement de l'Enfant et de l'Adolescent, Hospices Civils de Lyon, Lyon, France
* 7Laboratoire Parcours Santé Systémique (Equipe d'Accueil 4129), Université de Lyon, Université Claude Bernard-Lyon 1, Lyon, France
* 8Centre PSYRENE, Lyon, France
* 9CERMEP – Imagerie du Vivant, Université de Lyon, Lyon, France
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.